Back to results

Helsingin yliopisto

Identification of intravasation sites for metastatic biomarker development

Abstract

dc:description.abstract

Metastatic breast cancer is a leading cause of mortality in women worldwide. The key to metastatic progression is the ability of cancer cells to breach the endothelial basement membrane and enter the vasculature. It has long been believed that the process of intravasation is preceded by local invasion, and yet, several studies have detected circulating tumour cells at earlier disease stages. This suggests that intravasation may occur without detectable invasion into the surrounding microenvironment. To investigate this, we developed a vascular labelling strategy that incorporates three components to collectively mark sites of intravasation, allowing for detailed analysis of their molecular and structural characteristics. In this thesis, we validate first the surface expression of two fluorophores, EGFP and mT2. Following surface expression, we show that a recombinant protein moiety binds specifically to EGFP expressed on the surface. Building on this specific cell-surface interaction, we bound the targeting moiety to a large molecular weight dextran that is retained in the vasculature, coupled with fluorescent streptavidin for intravital imaging. Combining these components, we were successful in performing intravital imaging to identify differentially labelled blood vessels, indicating possible intravasation sites. Future work will involve confirmation of the specificity of the labelling approach for sites of intravasation, followed by laser capture microdissection coupled to proteomics for molecular assessment of the changes at these sites of breached vasculature. Importantly, by working with biobanks and clinical collaborators, identified markers of intravasation will be validated against large clinical cohorts to provide actionable therapeutic targets and novel biomarkers for disease stratification, with the central goal of improving patient outcomes from this work.

Degree

thesis:*
Grantor dc:publisher
Helsingin yliopisto
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Yassine, Hassan

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • In Copyright 1.0
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/10138/633161
OAI identifier oai:identifier
oai:helda.helsinki.fi:10138/633161

Chain of custody

source
Harvested from
University of Helsinki
Base URL
helda.helsinki.fi/server/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
citation

Yassine, Hassan. Identification of intravasation sites for metastatic biomarker development. Helsingin yliopisto, 2026. http://hdl.handle.net/10138/633161